[Neuron specific enolase-producing IgD multiple myeloma with high serum amylase activity]. 1995

T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
Japan Research Foundation for Chronic Diseases and Rehabilitation Affilated Hospital, Sakuragaoka Hospital.

A 68-year-old man who was admitted to our hospital because of general fatigue and anorexia. He was diagnosed as suffering from neuron specific enolase (NSE)-producing IgD-lambda type multiple myeloma with high activity of serum amylase, based on the detection of monoclonal IgD-lambda M-protein in the serum and urine, markedly high activities of salivary-type amylase and NSE in the serum, and immunohistochemical evidence of NSE and IgD in the myeloma cells. After two courses of alpha-IFN and VMCP chemotherapy, serum IgD, amylase and NSE decreased to normal levels. These observations indicate that NSE was ectopically produced by myeloma cells.

UI MeSH Term Description Entries
D007072 Immunoglobulin D An immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES. IgD,IgD1,IgD2
D007145 Immunoglobulin kappa-Chains One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig kappa Chains,Immunoglobulins, kappa-Chain,kappa-Immunoglobulin Light Chains,Immunoglobulin kappa-Chain,kappa-Chain Immunoglobulins,kappa-Immunoglobulin Light Chain,kappa-Immunoglobulin Subgroup VK-12,kappa-Immunoglobulin Subgroup VK-21,Chains, Ig kappa,Immunoglobulin kappa Chain,Immunoglobulin kappa Chains,Immunoglobulins, kappa Chain,Light Chain, kappa-Immunoglobulin,Light Chains, kappa-Immunoglobulin,kappa Chain Immunoglobulins,kappa Chains, Ig,kappa Immunoglobulin Light Chain,kappa Immunoglobulin Light Chains,kappa Immunoglobulin Subgroup VK 12,kappa Immunoglobulin Subgroup VK 21,kappa-Chain, Immunoglobulin,kappa-Chains, Immunoglobulin
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010751 Phosphopyruvate Hydratase A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity. Enolase,Neuron-Specific Enolase,2-Phospho-D-Glycerate Hydro-Lyase,2-Phospho-D-Glycerate Hydrolase,2-Phosphoglycerate Dehydratase,Enolase 2,Enolase 3,Muscle-Specific Enolase,Nervous System-Specific Enolase,Non-Neuronal Enolase,alpha-Enolase,beta-Enolase,gamma-Enolase,2 Phospho D Glycerate Hydro Lyase,2 Phospho D Glycerate Hydrolase,2 Phosphoglycerate Dehydratase,Dehydratase, 2-Phosphoglycerate,Enolase, Muscle-Specific,Enolase, Nervous System-Specific,Enolase, Neuron-Specific,Enolase, Non-Neuronal,Hydratase, Phosphopyruvate,Hydro-Lyase, 2-Phospho-D-Glycerate,Muscle Specific Enolase,Nervous System Specific Enolase,Neuron Specific Enolase,Non Neuronal Enolase,System-Specific Enolase, Nervous,alpha Enolase,beta Enolase,gamma Enolase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000681 Amylases A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. Diastase,Amylase

Related Publications

T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
January 1998, Ryoikibetsu shokogun shirizu,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
October 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
November 1992, Journal of internal medicine,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
November 2006, The Lancet. Oncology,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
May 2012, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
August 1989, Blood,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
September 1991, Archives of pathology & laboratory medicine,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
May 1998, Digestive diseases and sciences,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
December 2012, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
T Nakajima, and T Noguchi, and Y Kumahara, and A Sugihara, and T Yamazaki, and T Iwasaki, and T Hamano, and E Kakishita
February 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Copied contents to your clipboard!